Literature DB >> 28181005

The Pseudomonas aeruginosa Exoenzyme Y: A Promiscuous Nucleotidyl Cyclase Edema Factor and Virulence Determinant.

K Adam Morrow1,2, Dara W Frank3,4, Ron Balczon2,5, Troy Stevens6,7,8.   

Abstract

Exoenzyme Y (ExoY) was identified as a component of the Pseudomonas aeruginosa type 3 secretion system secretome in 1998. It is a common contributor to the arsenal of type 3 secretion system effectors, as it is present in approximately 90% of Pseudomonas isolates. ExoY has adenylyl cyclase activity that is dependent upon its association with a host cell cofactor. However, recent evidence indicates that ExoY is not just an adenylyl cyclase; rather, it is a promiscuous cyclase capable of generating purine and pyrimidine cyclic nucleotide monophosphates. ExoY's enzymatic activity causes a characteristic rounding of mammalian cells, due to microtubule breakdown. In endothelium, this cell rounding disrupts cell-to-cell junctions, leading to loss of barrier integrity and an increase in tissue edema. Microtubule breakdown seems to depend upon tau phosphorylation, where the elevation of cyclic nucleotide monophosphates activates protein kinases A and G and causes phosphorylation of endothelial microtubule associated protein tau. Phosphorylation is a stimulus for tau release from microtubules, leading to microtubule instability. Phosphorylated tau accumulates inside endothelium as a high molecular weight, oligomeric form, and is then released from the cell. Extracellular high molecular weight tau causes a transmissible cytotoxicity that significantly hinders cellular repair following infection. Thus, ExoY may contribute to bacterial virulence in at least two ways; first, by microtubule breakdown leading to loss of endothelial cell barrier integrity, and second, by promoting release of a high molecular weight tau cytotoxin that impairs cellular recovery following infection.

Entities:  

Keywords:  Nucleotidyl cyclase; P. aeruginosa virulence; Permeability; Tau toxicity; cAMP compartmentalization

Mesh:

Substances:

Year:  2017        PMID: 28181005      PMCID: PMC6103630          DOI: 10.1007/164_2016_5003

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  61 in total

Review 1.  Role of Pseudomonas aeruginosa type III effectors in disease.

Authors:  Joanne Engel; Priya Balachandran
Journal:  Curr Opin Microbiol       Date:  2009-01-23       Impact factor: 7.934

2.  Calmodulin-induced conformational and hydrodynamic changes in the catalytic domain of Bordetella pertussis adenylate cyclase toxin.

Authors:  Johanna C Karst; Ana Cristina Sotomayor Pérez; J Iñaki Guijarro; Bertrand Raynal; Alexandre Chenal; Daniel Ladant
Journal:  Biochemistry       Date:  2010-01-19       Impact factor: 3.162

Review 3.  Signal transduction and regulation of lung endothelial cell permeability. Interaction between calcium and cAMP.

Authors:  T M Moore; P M Chetham; J J Kelly; T Stevens
Journal:  Am J Physiol       Date:  1998-08

4.  Filamin A is a phosphorylation target of membrane but not cytosolic adenylyl cyclase activity.

Authors:  Sarah L Sayner; Ron Balczon; Dara W Frank; Dermot M F Cooper; Troy Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-04-08       Impact factor: 5.464

5.  VE-cadherin trans-interactions modulate Rac activation and enhancement of lung endothelial barrier by iloprost.

Authors:  Anna A Birukova; Yufeng Tian; Oleksii Dubrovskyi; Noureddine Zebda; Nicolene Sarich; Xinyong Tian; Yingxiao Wang; Konstantin G Birukov
Journal:  J Cell Physiol       Date:  2012-10       Impact factor: 6.384

6.  A rod-shaped Pseudomonas phage.

Authors:  K Takeya; K Amako
Journal:  Virology       Date:  1966-01       Impact factor: 3.616

7.  Pseudomonas aeruginosa exotoxin Y is a promiscuous cyclase that increases endothelial tau phosphorylation and permeability.

Authors:  Cristhiaan D Ochoa; Mikhail Alexeyev; Viktoriya Pastukh; Ron Balczon; Troy Stevens
Journal:  J Biol Chem       Date:  2012-05-25       Impact factor: 5.157

8.  Adenylate cyclase activity of Pseudomonas aeruginosa ExoY can mediate bleb-niche formation in epithelial cells and contributes to virulence.

Authors:  Victoria Hritonenko; James J Mun; Connie Tam; Nathan C Simon; Joseph T Barbieri; David J Evans; Suzanne M J Fleiszig
Journal:  Microb Pathog       Date:  2011-08-09       Impact factor: 3.738

9.  Paradoxical cAMP-induced lung endothelial hyperpermeability revealed by Pseudomonas aeruginosa ExoY.

Authors:  Sarah L Sayner; Dara W Frank; Judy King; Hairu Chen; John VandeWaa; Troy Stevens
Journal:  Circ Res       Date:  2004-06-10       Impact factor: 17.367

10.  Actin activates Pseudomonas aeruginosa ExoY nucleotidyl cyclase toxin and ExoY-like effector domains from MARTX toxins.

Authors:  Alexander Belyy; Dorothée Raoux-Barbot; Cosmin Saveanu; Abdelkader Namane; Vasily Ogryzko; Lina Worpenberg; Violaine David; Veronique Henriot; Souad Fellous; Christien Merrifield; Elodie Assayag; Daniel Ladant; Louis Renault; Undine Mechold
Journal:  Nat Commun       Date:  2016-12-05       Impact factor: 14.919

View more
  12 in total

Review 1.  ExlA: A New Contributor to Pseudomonas aeruginosa Virulence.

Authors:  Philippe Huber
Journal:  Front Cell Infect Microbiol       Date:  2022-06-23       Impact factor: 6.073

2.  α-Tocopherol Attenuates the Severity of Pseudomonas aeruginosa-induced Pneumonia.

Authors:  Brant M Wagener; Naseem Anjum; Cilina Evans; Angela Brandon; Jaideep Honavar; Judy Creighton; Maret G Traber; Robert L Stuart; Troy Stevens; Jean-Francois Pittet
Journal:  Am J Respir Cell Mol Biol       Date:  2020-08       Impact factor: 6.914

3.  cAMP signaling primes lung endothelial cells to activate caspase-1 during Pseudomonas aeruginosa infection.

Authors:  Phoibe Renema; Kierra S Hardy; Nicole Housley; Grace Dunbar; Naga Annamdevula; Andrea Britain; Domenico Spadafora; Silas Leavesley; Thomas Rich; Jonathon P Audia; Diego F Alvarez
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-03-18       Impact factor: 5.464

Review 4.  Structure-Function Relationships Underlying the Capacity of Bordetella Adenylate Cyclase Toxin to Disarm Host Phagocytes.

Authors:  Jakub Novak; Ondrej Cerny; Adriana Osickova; Irena Linhartova; Jiri Masin; Ladislav Bumba; Peter Sebo; Radim Osicka
Journal:  Toxins (Basel)       Date:  2017-09-24       Impact factor: 4.546

5.  Pseudomonas aeruginosa ExoS Induces Intrinsic Apoptosis in Target Host Cells in a Manner That is Dependent on its GAP Domain Activity.

Authors:  Amber Kaminski; Kajal H Gupta; Josef W Goldufsky; Ha Won Lee; Vineet Gupta; Sasha H Shafikhani
Journal:  Sci Rep       Date:  2018-09-19       Impact factor: 4.379

Review 6.  Animal Models of Type III Secretion System-Mediated Pathogenesis.

Authors:  Julia A Hotinger; Aaron E May
Journal:  Pathogens       Date:  2019-11-22

Review 7.  High-Throughput Approaches for the Identification of Pseudomonas aeruginosa Antivirulents.

Authors:  Donghoon Kang; Liyang Zhang; Natalia V Kirienko
Journal:  mBio       Date:  2021-05-04       Impact factor: 7.867

8.  Exoenzyme Y Contributes to End-Organ Dysfunction Caused by Pseudomonas aeruginosa Pneumonia in Critically Ill Patients: An Exploratory Study.

Authors:  Brant M Wagener; Naseem Anjum; Sarah C Christiaans; Morgan E Banks; Jordan C Parker; Adam T Threet; Rashidra R Walker; Kayla D Isbell; Stephen A Moser; Troy Stevens; Mikhail F Alexeyev; Jonathon P Audia; Wito Richter; Kierra S Hardy; Lina Abou Saleh; Charity Morgan; Jean-François Pittet
Journal:  Toxins (Basel)       Date:  2020-06-04       Impact factor: 4.546

9.  Virulent Pseudomonas aeruginosa infection converts antimicrobial amyloids into cytotoxic prions.

Authors:  Sarah Voth; Meredith Gwin; Christopher Michael Francis; Ron Balczon; Dara W Frank; Jean-Francois Pittet; Brant M Wagener; Stephen A Moser; Mikhail Alexeyev; Nicole Housley; Jonathon P Audia; Scott Piechocki; Kayla Madera; Autumn Simmons; Michaela Crawford; Troy Stevens
Journal:  FASEB J       Date:  2020-05-15       Impact factor: 5.191

Review 10.  Perspectives on the Pseudomonas aeruginosa Type III Secretion System Effector ExoU and Its Subversion of the Host Innate Immune Response to Infection.

Authors:  Kierra S Hardy; Maxx H Tessmer; Dara W Frank; Jonathon P Audia
Journal:  Toxins (Basel)       Date:  2021-12-09       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.